The roles of hepatocyte growth factor/scatter factor and met receptor in human cancers (Review) (original) (raw)
Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor
Glenn Merlino
Proceedings of the National Academy of Sciences, 1997
View PDFchevron_right
Tumorigenesis induced by coexpression of human hepatocyte growth factor and the human met protooncogene leads to high levels of expression of the ligand and receptor
James Resau
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, 1993
View PDFchevron_right
Potent and selective inhibitors of the Met [hepatocyte growth factor/scatter factor (HGF/SF) receptor] tyrosine kinase block HGF/SF-induced tumor cell growth and invasion
Todd Miller
Molecular cancer therapeutics, 2003
View PDFchevron_right
Potent and selective inhibitors of the Met [hepatocyte growth factor/scatter …
Clinica MAM
Molecular Cancer …
View PDFchevron_right
Tumorigenesis Induced by Coexpression of Human Hepatocyte Growth Factor and the Human met Protooncogene Leads to High Levels of Expression of the Ligand and Receptor1
Ilan Tsarfaty
View PDFchevron_right
SF/HGF-c-Met autocrine and paracrine promote metastasis of hepatocellular carcinoma
qian xie
2001
View PDFchevron_right
Hepatocyte Growth Factor, a Key Tumor-Promoting Factor in the Tumor Microenvironment
Robert Galemmo
Cancers, 2017
View PDFchevron_right
Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition
Paul Morrison
Cytokine & Growth Factor Reviews, 2002
View PDFchevron_right
Hepatocyte growth factor/scatter factor is an autocrine factor for human normal bronchial epithelial and lung carcinoma cells
Jean Viallet
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, 1993
View PDFchevron_right
Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamine
Glenn Merlino
Oncogene, 2002
View PDFchevron_right
Co-overexpression of Met and hepatocyte growth factor promotes systemic metastasis in NCI-H460 non-small cell lung carcinoma cells
Bizhan Bandarchi, R. Navab
Neoplasia (New York, N.Y.), 2009
View PDFchevron_right
Hepatocyte growth factor/scatter factor stimulates chemotaxis and growth of malignant mesothelioma cells through c-met receptor
Robert Wondergem, D. Defoe
International Journal of Cancer, 1998
View PDFchevron_right
c-MET receptor tyrosine kinase as a molecular target in advanced hepatocellular carcinoma
Alessandro Granito
Journal of Hepatocellular Carcinoma, 2015
View PDFchevron_right
Hepatocyte growth factor/scatter factor expression and c-met in primary breast cancer
Ian McKay
Surgical Oncology, 1996
View PDFchevron_right
Hepatocyte Growth Factor/Scatter Factor Is an Autocrine Factor for Human Normal Bronchial Epithelial and Lung Carcinoma Cells1
Jean Viallet
2000
View PDFchevron_right
The hepatocyte growth factor/c-Met signaling pathway as a therapeutic target to inhibit angiogenesis
Donald McDonald
BMB Reports, 2008
View PDFchevron_right
The Hepatocyte Growth Factor Receptor: Structure, Function and Pharmacological Targeting in Cancer
Donald Bottaro
Current signal transduction therapy, 2011
View PDFchevron_right
Liver hepatocyte growth factor does not always correlate with hepatocellular proliferation in human liver lesions: its specific receptor c-met does
antonio ponzetto
Hepatology (Baltimore, Md.), 1996
View PDFchevron_right
Activation of hepatocyte growth factor/MET signaling initiates oncogenic transformation and enhances tumoraggressiveness in the murine prostate
ZJ Sun
Journal of Biological Chemistry
View PDFchevron_right
Met-HGF/SF mediates growth arrest and differentiation in T47D breast cancer cells
Rom Altstock, James Resau
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, 1999
View PDFchevron_right
Receptor chimeras indicate that the met tyrosine kinase mediates the motility and morphogenic responses of hepatocyte growth/scatter factor
Monica Naujokas
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, 1994
View PDFchevron_right
The biological role of HGF-MET axis in tumor growth and development of metastasis
Marcin Majka
Frontiers in Bioscience, 2008
View PDFchevron_right
“Invasive-growth” signaling by the Met/HGF receptor
luisa pugliese
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1997
View PDFchevron_right
Disassociation of met-mediated biological responses in vivo: the natural hepatocyte growth factor/scatter factor splice variant NK2 antagonizes growth but facilitates metastasis
Donald Bottaro
Molecular and cellular biology, 2000
View PDFchevron_right
Hepatocyte growth factor/scatter factor induces a variety of tissue-specific morphogenic program in epithelial cells
Volker Brinkmann
The Journal of Cell Biology
View PDFchevron_right
Hepatocyte growth factor/scatter factor induces not only scattering but also cohort migration of human colorectal-adenocarcinoma cells
Hiroshi Itoh
International Journal of Cancer, 1998
View PDFchevron_right
Overexpression of the Hepatocyte Growth Factor (HGF) Receptor (Met) and Presence of a Truncated and Activated Intracellular HGF Receptor Fragment in Locally Aggressive/Malignant Human Musculoskeletal Tumors
John-olov Jansson
The American Journal of Pathology, 2000
View PDFchevron_right
Targeting the HGF/Met signaling pathway in cancer therapy
Donald Bottaro
Expert Opinion on Therapeutic Targets, 2012
View PDFchevron_right
Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product
Donald Bottaro, Jeffrey Rubin
Science, 1991
View PDFchevron_right
Structural basis of hepatocyte growth factor/scatter factor and MET signalling
Tom Blundell
Proceedings of the National Academy of Sciences of the United States of America, 2006
View PDFchevron_right